Platinum Resistant High Grade Epithelial Ovarian Cancer
specificAn ovarian high-grade serous adenocarcinoma that progresses between one and six months of completing platinum therapy.
10
Centers
10
Active Trials
—
Cancer Funding
Top Centers for Platinum Resistant High Grade Epithelial Ovarian Cancer(10)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 55.0 |
| 2 | NCI Comprehensive Active Research Program | 55.0 |
| 3 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 55.0 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 55.0 |
| 5 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 55.0 |
| 6 | Hollings Cancer CenterCharleston, SC NCI Clinical Active Research Program | 55.0 |
| 7 | NCI Basic_laboratory Active Research Program | 55.0 |
| 8 | University of Illinois Cancer CenterChicago, IL Active Research Program | 55.0 |
| 9 | Cancer Center at IllinoisUrbana, IL Active Research Program | 55.0 |
| 10 | Legorreta Cancer Center at Brown UniversityProvidence, RI Active Research Program | 55.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →